NASDAQ:RMTI - Rockwell Medical Stock Price, Price Target & More

$5.38 -0.16 (-2.89 %)

(As of 04/25/2018 04:00 PM ET)

Previous Close$5.54

Today's Range$5.27 - $5.58

52-Week Range$4.84 - $8.98

Volume191,070 shs

Average Volume249,591 shs

Market Capitalization$284.21 million

P/E Ratio-10.65

Dividend YieldN/A

Beta2.19

About Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment. It also provides Calcitriol, a generic active vitamin D injection, which is indicated for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, Renalpure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubings, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its concentrated dialysate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. The company's target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan.

Receive RMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment

Sub-IndustryHealth Care Equipment

SectorMedical

SymbolNASDAQ:RMTI

CUSIP77437410

Webwww.rockwellmed.com

Phone248-960-9009

Debt

Debt-to-Equity RatioN/A

Current Ratio5.34%

Quick Ratio4.51%

Price-To-Earnings

Trailing P/E Ratio-10.65

Forward P/E Ratio-14.94

P/E GrowthN/A

Sales & Book Value

Annual Sales$57.30 million

Price / Sales4.86

Cash FlowN/A

Price / CashN/A

Book Value$0.64 per share

Price / Book8.41

Profitability

EPS (Most Recent Fiscal Year)($0.51)

Net Income$-25,920,000.00

Net Margins-45.24%

Return on Equity-61.67%

Return on Assets-37.77%

Miscellaneous

Employees300

Outstanding Shares51,770,000

How to Become a New Pot Stock Millionaire

Rockwell Medical (NASDAQ:RMTI) Frequently Asked Questions

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

How were Rockwell Medical's earnings last quarter?

Rockwell Medical (NASDAQ:RMTI) issued its quarterly earnings data on Thursday, March, 15th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.13) by $0.05. The business earned $14.84 million during the quarter, compared to analyst estimates of $13.20 million. Rockwell Medical had a negative return on equity of 61.67% and a negative net margin of 45.24%. Rockwell Medical's revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.10) EPS. View Rockwell Medical's Earnings History.

When is Rockwell Medical's next earnings date?

Rockwell Medical is scheduled to release their next quarterly earnings announcement on Monday, May, 7th 2018. View Earnings Estimates for Rockwell Medical.

What price target have analysts set for RMTI?

1 equities research analysts have issued 1-year price targets for Rockwell Medical's stock. Their predictions range from $11.00 to $11.00. On average, they expect Rockwell Medical's stock price to reach $11.00 in the next twelve months. View Analyst Ratings for Rockwell Medical.

Who are some of Rockwell Medical's key competitors?

Some companies that are related to Rockwell Medical include Cutera (CUTR), Viewray (VRAY), Vision Sciences (CGNT), Fonar (FONR), Helius Medical Technologies (HSDT), Zynex (ZYXI), Biolife Solutions (BLFS), Second Sight Medical (EYES), Viveve Medical (VIVE), Edap Tms (EDAP), IRIDEX (IRIX), BioSig Technologies (BSGM), Semler Scientific (SMLR), Stereotaxis (STXS) and Soleno Therapeutics (SLNO).

Who are Rockwell Medical's key executives?

Rockwell Medical's management team includes the folowing people:

Mr. Robert L. Chioini, Founder & CEO (Age 53)
Mr. Thomas E. Klema CPA, MBA, Chief Financial Officer, VP of Fin., Treasurer and Sec. (Age 64)
Dr. Ajay Gupta M.D., Chief Scientific Officer and Member of Scientific Advisory Board (Age 60)
Dr. Raymond Dennis Pratt M.D., FACP, Chief Medical Officer (Age 67)

Has Rockwell Medical been receiving favorable news coverage?

Media headlines about RMTI stock have been trending somewhat positive this week, according to Accern. The research group scores the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Rockwell Medical earned a coverage optimism score of 0.09 on Accern's scale. They also assigned news coverage about the company an impact score of 46.38 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include RICHMOND BROTHERS, INC. (10.80%). Company insiders that own Rockwell Medical stock include David S Richmond and Kenneth L Holt. View Institutional Ownership Trends for Rockwell Medical.

How do I buy shares of Rockwell Medical?

Shares of RMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $5.38.

How big of a company is Rockwell Medical?

Rockwell Medical has a market capitalization of $284.21 million and generates $57.30 million in revenue each year. The company earns $-25,920,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis. Rockwell Medical employs 300 workers across the globe.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 30142 S WIXOM RD, WIXOM MI, 48393. The company can be reached via phone at 248-960-9009 or via email at [email protected]

MarketBeat Community Rating for Rockwell Medical (RMTI)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		195 (Vote Outperform)
Underperform Votes:		219 (Vote Underperform)
Total Votes:		414

MarketBeat's community ratings are surveys of what our community members think about Rockwell Medical and other stocks. Vote "Outperform" if you believe RMTI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMTI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Rockwell Medical (NASDAQ:RMTI) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

1 Wall Street analysts have issued ratings and price targets for Rockwell Medical in the last 12 months. Their average twelve-month price target is $11.00, suggesting that the stock has a possible upside of 104.46%. The high price target for RMTI is $11.00 and the low price target for RMTI is $11.00. There are currently 1 strong buy rating for the stock, resulting in a consensus rating of "Strong Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Strong Buy	Strong Buy	Strong Buy	Buy
Consensus Rating Score:	4.00	4.00	4.00	2.67
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 1 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 1 Strong Buy Rating(s)	1 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 1 Strong Buy Rating(s)
Consensus Price Target:	$11.00	$11.00	$11.00	$9.3333
Price Target Upside:	104.46% upside	76.28% upside	76.28% upside	49.57% upside

Rockwell Medical (NASDAQ:RMTI) Consensus Price Target History

Price Target History for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ:RMTI) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
8/14/2017	Ifs Securities	Initiated Coverage	Strong-Buy	$11.00	Medium
11/9/2016	BTIG Research	Reiterated Rating	Buy	$12.00	N/A
11/8/2016	Bank of America	Downgrade	Neutral -> Underperform	$9.00 -> $5.00	N/A

(Data available from 4/25/2016 forward)

Rockwell Medical (NASDAQ:RMTI) Earnings History and Estimates Chart

Earnings by Quarter for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ:RMTI) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.36 EPS
Next Year EPS Consensus Estimate: $0.04 EPS

Rockwell Medical (NASDAQ RMTI) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/7/2018		($0.10)					N/A
3/15/2018	Q4 2017	($0.13)	($0.18)	$13.20 million	$14.84 million	View	Listen
11/8/2017	Q3 2017	($0.10)	($0.0960)	$13.33 million	$14.63 million	View	N/A
8/9/2017	Q2 2017	($0.10)	($0.14)	$13.05 million	$13.24 million	View	Listen
5/9/2017	Q1 2017	($0.09)	($0.09)	$12.66 million	$14.60 million	View	Listen
3/15/2017	Q4 2016	($0.09)	($0.10)	$15.45 million	$13.39 million	View	N/A
11/7/2016	Q3	($0.10)	($0.09)	$15.40 million	$12.81 million	View	Listen
8/8/2016	Q2	($0.10)	($0.11)	$13.86 million	$12.50 million	View	N/A
5/10/2016	Q1	($0.08)	($0.10)	$15.25 million	$13.63 million	View	Listen
2/29/2016	Q4	$0.02	($0.12)	$19.98 million	$14.10 million	View	Listen
11/9/2015	Q315	($0.02)	($0.05)	$14.93 million	$14.40 million	View	Listen
8/4/2015	Q215	($0.10)	($0.05)	$11.84 million	$12.96 million	View	Listen
5/7/2015	Q414	($0.10)	($0.07)	$13.20 million	$13.90 million	View	N/A
2/26/2015	Q4	($0.10)	($0.14)	$13.51 million	$14.40 million	View	N/A
11/10/2014	Q314	($0.10)	($0.10)	$13.40 million	$13.70 million	View	N/A
7/31/2014	Q2	($0.13)	($0.08)	$13.45 million	$13.00 million	View	N/A
5/12/2014	Q1	($0.14)	($0.20)	$14.22 million	$13.00 million	View	N/A
2/26/2014		($0.28)	($0.21)	$14.11 million	$13.97 million	View	N/A
11/5/2013	Q3 2013	($0.22)	($0.34)	$13.90 million	$13.09 million	View	N/A
8/1/2013	Q2 2013	($0.31)	($0.38)	$13.58 million	$12.98 million	View	N/A
5/8/2013	Q1 2013	($0.34)	($0.72)	$13.11 million	$12.34 million	View	N/A
3/18/2013	Q4 2012	($0.44)	($0.66)			View	N/A
11/8/2012	Q312	($0.50)	($0.86)	$12.57 million	$12.70 million	View	N/A
8/7/2012	Q2 2012	($0.48)	($0.58)			View	N/A
5/3/2012	Q1 2012	($0.43)	($0.54)			View	N/A
3/1/2012	Q4 2011	($0.17)	($0.49)			View	N/A
11/3/2011	Q3 2011	($0.25)	($0.28)			View	N/A
8/4/2011	Q2 2011	($0.20)	($0.26)			View	N/A
5/5/2011	Q1 2011	($0.14)	($0.17)			View	N/A
3/3/2011	Q4 2010	($0.06)	($0.10)			View	N/A
11/4/2010	Q3 2010	($0.02)	($0.04)			View	N/A
8/5/2010	Q2 2010	($0.04)	$0.01			View	N/A
5/5/2010	Q1 2010	($0.06)	($0.02)			View	N/A
3/10/2010	Q4 2009	($0.06)	($0.03)			View	N/A
11/4/2009	Q3 2009	($0.11)	($0.11)			View	N/A
8/10/2009	Q2 2009		($0.12)			View	N/A
5/11/2009	Q1 2009		($0.12)			View	N/A
3/16/2009	Q4 2008		($0.22)			View	N/A
11/13/2008	Q3 2008		($0.18)			View	N/A
8/12/2008	Q2 2008		($0.08)			View	N/A
5/7/2008	Q1 2008		($0.09)			View	N/A
3/6/2008	Q4 2007		($0.01)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Rockwell Medical (NASDAQ:RMTI) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Rockwell Medical (NASDAQ RMTI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.90%
Institutional Ownership Percentage: 21.53%

Insider Trading History for Rockwell Medical (NASDAQ:RMTI)

Rockwell Medical (NASDAQ RMTI) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/15/2017	David S Richmond	Insider	Sell	36	$6.53	$235.08	176,376
3/22/2017	David S Richmond	Insider	Buy	37,210	$5.84	$217,306.40	176,412
3/16/2017	Kenneth L Holt	Director	Sell	6,000	$5.98	$35,880.00	17,430
11/11/2016	Kenneth L Holt	Director	Sell	19,725	$5.16	$101,781.00	32,355
11/1/2016	Kenneth L Holt	Director	Sell	1,400	$5.92	$8,288.00	38,355
10/21/2016	Kenneth L Holt	Director	Sell	2,533	$6.04	$15,299.32	41,338
9/19/2016	Kenneth L Holt	Director	Sell	8,075	$6.81	$54,990.75	46,858
8/25/2016	Kenneth L Holt	Director	Sell	9,520	$6.37	$60,642.40	56,048
8/16/2016	Kenneth L Holt	Director	Sell	3,692	$7.31	$26,988.52	63,475
12/4/2015	Ronald D. Boyd	Director	Sell	12,500	$10.58	$132,250.00	32,500
8/14/2015	Robert L Chioini	CEO	Buy	4,910	$11.96	$58,723.60
8/13/2015	Raymond Dennis Pratt	VP	Buy	5,000	$11.54	$57,700.00
8/13/2015	Robert L Chioini	CEO	Buy	5,090	$11.51	$58,585.90
8/27/2012	David A Hagelstein	Major Shareholder	Buy	7,000	$8.10	$56,700.00

(Data available from 1/1/2013 forward)

Rockwell Medical (NASDAQ RMTI) News Headlines

Source:

Date	Headline
	Analysts Expect Rockwell Medical Inc (RMTI) to Post -$0.13 EPS www.americanbankingnews.com - April 20 at 9:18 AM
	Rockwell Medical (RMTI) Upgraded to "Sell" at BidaskClub www.americanbankingnews.com - April 10 at 7:19 PM
	Active-Investors: Blog Exposure - Impax Launched a Generic Version of Estrace(R) Cream www.finanznachrichten.de - April 10 at 5:31 PM
	Does Rockwell Medical Inc (NASDAQ:RMTI) Go Up With The Market? finance.yahoo.com - April 10 at 5:31 PM
	Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings globenewswire.com - April 7 at 4:34 PM
	Rockwell Medical (RMTI) Lifted to "Buy" at Zacks Investment Research www.americanbankingnews.com - April 5 at 4:38 PM
	Rockwell Medical Announces Triferic Presentations at the 2018 National Kidney Foundation Spring Clinical Meetings finance.yahoo.com - April 5 at 10:08 AM
	Zacks: Brokerages Anticipate Rockwell Medical Inc (RMTI) to Announce -$0.13 Earnings Per Share www.americanbankingnews.com - April 3 at 11:33 AM
	Rockwell Medical Sees Unusually Large Options Volume (RMTI) www.americanbankingnews.com - March 28 at 6:44 AM
	Rockwell Medical (RMTI) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - March 27 at 2:54 PM
	Rockwell Medical (RMTI) & Edap Tms (EDAP) Financial Survey www.americanbankingnews.com - March 22 at 11:12 PM
	Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology - GlobeNewswire (press release) globenewswire.com - March 21 at 8:44 AM
	Wired News – Pfizer Signs Collaboration Deal with BioDuro to Develop Shelf-Stable Fluorosulfation Reagent finance.yahoo.com - March 21 at 8:44 AM
	Rockwell Medical Announces Triferic Presentations at the 2018 Asia Pacific Congress of Nephrology finance.yahoo.com - March 20 at 5:19 PM
	Rockwell Medical (RMTI) Raised to "Hold" at BidaskClub www.americanbankingnews.com - March 18 at 4:58 PM
	Why Kratos Defense & Security Solutions, Bitauto Holdings, and Rockwell Medical Slumped Today - Motley Fool www.fool.com - March 17 at 8:23 AM
	Zacks: Brokerages Anticipate Rockwell Medical Inc (RMTI) to Post -$0.10 EPS www.americanbankingnews.com - March 17 at 7:30 AM
	Rockwell Medical's (RMTI) CEO Rob Chioini on Q4 2017 Results - Earnings Call Transcript seekingalpha.com - March 16 at 6:31 PM
	Why Kratos Defense & Security Solutions, Bitauto Holdings, and Rockwell Medical Slumped Today finance.yahoo.com - March 16 at 6:31 PM
	Edited Transcript of RMTI earnings conference call or presentation 15-Mar-18 8:30pm GMT finance.yahoo.com - March 16 at 6:31 PM
	Rockwell Medical (RMTI) Releases Quarterly Earnings Results, Misses Estimates By $0.05 EPS www.americanbankingnews.com - March 15 at 9:02 PM
	Rockwell Medical Q4 Earnings Preview finance.yahoo.com - March 15 at 6:14 PM
	Rockwell Medical Reports Fourth Quarter and Year End 2017 Results finance.yahoo.com - March 15 at 6:14 PM
	Rockwell Medical, Inc. to Host Earnings Call finance.yahoo.com - March 15 at 6:14 PM
	Rockwell Medical, Inc. Appoints Two Independent and Experienced ... - GlobeNewswire (press release) globenewswire.com - March 14 at 8:29 AM
	Rockwell Medical, Inc. Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors feeds.benzinga.com - March 13 at 4:48 PM
	Want To Invest In Rockwell Medical Inc (NASDAQ:RMTI)? Here’s How It Performed Lately finance.yahoo.com - March 13 at 8:22 AM
	Rockwell Medical Schedules Year End 2017 Earnings Call - Nasdaq www.nasdaq.com - March 12 at 8:53 AM
	Rockwell Medical Schedules Year End 2017 Earnings Call finance.yahoo.com - March 12 at 8:53 AM
	Rockwell Medical (RMTI) Set to Announce Earnings on Tuesday www.americanbankingnews.com - March 6 at 2:32 AM
	Research Report Identifies Rockwell Medical, NetScout, Almost Family, Emerge Energy Services LP, Quality, and Parker-Hannifin with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement finance.yahoo.com - March 2 at 8:14 AM
	Rockwell Medical Announces Triferic Presentations at the 2018 Annual Dialysis Conference - GlobeNewswire (press release) globenewswire.com - March 1 at 8:13 AM
	Rockwell Medical Announces Triferic Presentations at the 2018 Annual Dialysis Conference finance.yahoo.com - February 28 at 6:05 PM
	ValuEngine Lowers Rockwell Medical (RMTI) to Strong Sell www.americanbankingnews.com - February 4 at 3:24 PM
	Rockwell Medical Sees Unusually High Options Volume (RMTI) www.americanbankingnews.com - January 21 at 1:28 AM
	Rockwell Medical (RMTI) Stock Rating Upgraded by BidaskClub www.americanbankingnews.com - January 6 at 4:26 PM
	Zacks Investment Research Lowers Rockwell Medical (RMTI) to Sell www.americanbankingnews.com - January 4 at 3:38 PM
	Rockwell Medical (RMTI) Cut to "Sell" at BidaskClub www.americanbankingnews.com - December 22 at 6:12 PM
	Rockwell Medical, Inc. – Value Analysis (NASDAQ:RMTI) : December 18, 2017 finance.yahoo.com - December 19 at 5:31 AM
	Rockwell Medical (RMTI) Upgraded to Hold at BidaskClub www.americanbankingnews.com - December 16 at 12:02 PM
	Rockwell Medical, Inc. breached its 50 day moving average in a Bullish Manner : RMTI-US : December 15, 2017 finance.yahoo.com - December 15 at 3:16 PM
	Rockwell Medical Technologies (RMTI) Signs Exclusive License ... - StreetInsider.com www.streetinsider.com - December 15 at 5:33 AM
	Rockwell Medical Technologies (RMTI) Announces Exclusive License Agreement with Quimica Europea to Commercialize Triferic in Peru www.streetinsider.com - December 14 at 3:16 PM
	Rockwell Medical Signs Exclusive License Agreement with Comercializadora BioRenal SpA to Commercialize Triferic® in Chile finance.yahoo.com - December 14 at 3:16 PM
	Rockwell Medical Technologies (RMTI) Announces Exclusive License Agreement with Quimica Europea to ... - StreetInsider.com www.streetinsider.com - December 12 at 3:15 PM
	Rockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic® in Peru finance.yahoo.com - December 12 at 3:15 PM
	ETFs with exposure to Rockwell Medical, Inc. : December 12, 2017 finance.yahoo.com - December 12 at 3:15 PM
	Zacks Investment Research Upgrades Rockwell Medical (RMTI) to "Hold" www.americanbankingnews.com - December 1 at 12:28 AM
	ETFs with exposure to Rockwell Medical, Inc. : November 27, 2017 finance.yahoo.com - November 27 at 4:22 PM
	Smoke And Mirrors At Rockwell Medical? - Seeking Alpha seekingalpha.com - November 26 at 5:52 PM

Rockwell Medical (NASDAQ:RMTI) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Rockwell Medical (NASDAQ:RMTI) Income Statement, Balance Sheet and Cash Flow Statement

Rockwell Medical (NASDAQ RMTI) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff